Patents
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/2011
12/14/2011CN102277373A 一种减毒沙门氏菌分泌表达的日本血吸虫疫苗表达载体及其应用 An attenuated Salmonella vaccine secretory expression of Schistosoma expression vector and its application
12/14/2011CN102277368A 鸭病毒性肠炎病毒感染性重组克隆系统及构建方法和应用 Duck viral enteritis virus recombinant cloning systems and construction methods and applications
12/14/2011CN102277367A 鸭病毒性肠炎病毒疫苗株感染性克隆系统及其构建方法和应用 Duck viral enteritis virus vaccine strains of infectious clone system and its construction method and application
12/14/2011CN102277365A Hpv58型e6/e7融合基因及治疗性复合基因疫苗 Hpv58 type e6 / e7 complex fusion gene and gene therapy vaccines
12/14/2011CN102277361A 一种石斑鱼虹彩病毒保护性抗原的筛选方法 One kind of grouper iridescent virus protective antigen screening method of
12/14/2011CN102277333A 抗口蹄疫病毒的单克隆抗体及其识别的抗原表位和应用 Monoclonal anti-FMDV antibodies and recognize epitopes and applications
12/14/2011CN102277330A 人CD3+CD8+γδT淋巴细胞及其制备方法与应用 Human CD3 + CD8 + γδT lymphocytes and its preparation method and application
12/14/2011CN102276730A 金黄色葡萄球菌IsdB<sub>id</sub>-TRAP融合蛋白制备方法及其应用 Staphylococcus aureus IsdB <sub> id </ sub> -TRAP fusion protein preparation method and its application
12/14/2011CN102276726A 肝细胞生长因子受体活性基团的融合蛋白 Hepatocyte growth factor receptor fusion protein reactive groups
12/14/2011CN102276725A 隐孢子虫CTL和Th混合多表位基因和融合蛋白及应用 Cryptosporidium CTL and Th mixed multi-epitope genes and fusion proteins and application
12/14/2011CN102276723A 抗VEGF单克隆抗体Vancolizumab及其应用 Anti-VEGF monoclonal antibody and its application Vancolizumab
12/14/2011CN102276722A 新型血管内皮生长因子人源化单克隆抗体 The new vascular endothelial growth factor humanized monoclonal antibody
12/14/2011CN102276720A 一种高生物活性卵黄抗体及其制备方法 A highly bioactive yolk antibodies and methods
12/14/2011CN102276700A 一种猪戊型肝炎病毒抗原表位及它的应用 Pig hepatitis E virus epitopes and its application
12/14/2011CN102276697A 幽门螺杆菌抗原hla限制性免疫显性表位肽及应用 Helicobacter pylori antigen hla restricted immunodominant epitope peptide and its application
12/14/2011CN102274523A 一种猪圆环病毒Ⅱ型核酸疫苗及其制备方法 One kind of porcine circovirus type Ⅱ DNA vaccine and its preparation method
12/14/2011CN102274516A 含有大分子的持续释放眼内植入物及相关方法 Material and associated method for a sustained release intraocular implant containing macromer
12/14/2011CN102274509A 治疗或预防癌症的药物 Treating or preventing cancer drugs
12/14/2011CN102274508A 一种治疗或预防癌症的药物 A medicament for the treatment or prevention of cancer
12/14/2011CN102274507A 一种用于治疗或预防癌症的药物 A drug for treating or preventing cancer
12/14/2011CN102274506A 治疗或预防癌症的药物 Treating or preventing cancer drugs
12/14/2011CN102274505A 治疗或预防癌症的药物 Treating or preventing cancer drugs
12/14/2011CN102274504A 治疗或预防癌症的药物 Treating or preventing cancer drugs
12/14/2011CN102274503A 治疗或预防癌症的药物 Treating or preventing cancer drugs
12/14/2011CN102274502A 治疗或预防癌症的药物 Treating or preventing cancer drugs
12/14/2011CN102274501A 一种治疗或预防癌症的药物 A medicament for the treatment or prevention of cancer
12/14/2011CN102274500A 一种用于治疗或预防癌症的药物 A drug for treating or preventing cancer
12/14/2011CN102274499A 用于治疗或预防癌症的药物 Medicament for treating or preventing cancer
12/14/2011CN102274498A 一种口蹄疫病毒纳米乳佐剂疫苗及其制备方法 One kind of foot and mouth disease virus nanoemulsion vaccine adjuvant and its preparation method
12/14/2011CN102274497A 一种A/Asia I型口蹄疫病毒两价基因工程多肽疫苗及制备方法和用途 One kind of A / Asia I FMDV two price genetically engineered peptide vaccine and preparation and use
12/14/2011CN102274496A 一种O/Asia I型口蹄疫病毒两价基因工程多肽疫苗及制备方法和用途 One kind of O / Asia I FMDV two price genetically engineered peptide vaccine and preparation and use
12/14/2011CN102274495A 抗大肠杆菌和沙氏门菌的禽类组合疫苗 Poultry combination vaccine against E. coli bacteria and Sabouraud door
12/14/2011CN102274494A 副溶血性弧菌类毒素疫苗的制备方法与用途 Preparation of Vibrio parahaemolyticus toxoid vaccine and uses
12/14/2011CN102274183A 一种多囊脂质体制备方法和应用 A multi-sac liposome preparation methods and applications
12/14/2011CN102274165A 一种基于抗TNF-α单克隆抗体的用于治疗银屑病的软膏 Based on the anti-TNF-α monoclonal antibody for the treatment of psoriasis ointment
12/14/2011CN101857861B 一种免疫识别分子标记及其构建和应用 Immune recognition and its construction and application of molecular markers
12/14/2011CN101805408B 抗肿瘤溶栓双效嵌合蛋白及其制备方法和应用 Anti-tumor effect of thrombolytic double chimeric protein and its preparation method and application
12/14/2011CN101671690B 含日本血吸虫基因的重组表达载体及应用 Schistosoma japonicum gene containing a recombinant expression vector and application
12/14/2011CN101396332B 脚用除臭剂及其制备方法 Foot deodorant with its preparation method
12/14/2011CN101307314B 重组噬菌体rbp/t7的构建及用其制备2型糖尿病疫苗的方法 Construction of recombinant phage rbp / t7 and prepared with its type 2 diabetes vaccine
12/14/2011CN101284130B 利用逆向基因工程技术开发蛋白质疫苗与禽流感疫苗的方法 Using reverse genetic engineering technology to develop protein vaccines and avian influenza vaccine approach
12/14/2011CN101137748B 粘液瘤病毒与雷帕霉素的组合在治疗性处理中的应用 Combination with rapamycin myxoma virus used in the therapeutic treatment of
12/14/2011CN101102791B 抗血管内皮生长因子受体-1的抗体 Anti-vascular endothelial growth factor receptor-1 antibody
12/14/2011CN101027322B 促红细胞生成素受体结合抗体 Erythropoietin receptor antibody
12/13/2011US8076470 VMP-like sequences of pathogenic Borrelia species and strains
12/13/2011US8076469 Nucleotide sequences coding interferon inducer for use in detection of mycobacterial infection
12/13/2011US8076460 Antibody and inhibitor, and transfection method or kit using them
12/13/2011US8076459 Multispecfic deimmunized CD3-binders
12/13/2011US8076283 Methods for treating congestive heart failure
12/13/2011US8076133 Method for obtaining antigen-specific Tr1 regulatory lymphocytes
12/13/2011US8076100 Genetic engineering; vaccine; induction antibodies
12/13/2011US8076098 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism
12/13/2011US8076096 Alteration of cell membrane with FasL
12/13/2011US8076087 Galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases
12/13/2011US8076085 Methods and means relating to hepatitis B infection
12/13/2011US8076066 Gene detection assay for improving the likelihood of an effective response to a HER2 antibody cancer therapy
12/13/2011US8076060 Administering to a human a composition containing an effective amount of an agent capable of stimulating an immunological response resulting in reduced intraocular pressure
12/13/2011US8076059 Adjuvant capable of specifically activating the adaptive immune response
12/13/2011US8075916 Poly(organophosphazene) hydrogels for drug delivery, preparation method thereof and use thereof
12/13/2011US8075903 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4 or antigenic chimeric dengue viruses 1, 2, 3, and 4
12/13/2011US8075900 Melanoma associated peptide analogues and vaccines against melanoma
12/13/2011US8075899 Peptides of the A-chain of proinsulin or insulin
12/13/2011US8075898 Mite allergen
12/13/2011US8075897 Allergen peptide fragments and use thereof
12/13/2011US8075896 Method to enhance an immune response of nucleic acid vaccination
12/13/2011US8075895 Identification of antigenic peptides from multiple myeloma cells
12/13/2011US8075894 Use of soluble CD164 in inflammatory and/or autoimmune disorders
12/13/2011US8075893 Pharmaceutical composition of F(ab′)2 antibody fragments and a process for the preparation thereof
12/13/2011US8075892 Treatment with anti-ErbB2 antibodies
12/13/2011US8075891 Antibodies that bind ALS specific epitopes and methods of making
12/13/2011US8075890 Method for making humanized antibodies
12/13/2011US8075889 Antibody molecules having specificity for human IL-6
12/13/2011US8075888 Methods of treatment using antibodies to IL-17 homologous polypeptides
12/13/2011US8075887 Cytokine specific immunoglobulin for use in diagnosis, prevention and treatment ,of cell proliferative, inflammatory, allergic, respiratory, autoimmune and arthritic disorders
12/13/2011US8075886 Method of treatment using an anti-IL-B50 antibody
12/13/2011US8075885 Methods of treating heart failure using an anti-GM-CSF antibody
12/13/2011US8075884 Antibodies to OX-2/CD200 and uses thereof
12/13/2011CA2495795C Cross-linkers with high reactivity and solubility and their use in the preparation of conjugates for targeted delivery of small molecule drugs
12/13/2011CA2475821C Group b streptococcus antigens
12/13/2011CA2446197C Use of alpha 1-antichymotrypsin polypeptides, or nucleic acids encoding them, or of a cell which is expressing an act polypeptide, or a nucleic acid encoding it, for treatment and/or prevention of diabetes-associated and/or arterial poorly healing wounds and for identifying pharmacologically active substances
12/13/2011CA2441048C Novel compound for treatment of allergy and asthma
12/13/2011CA2358520C Soluble receptor br43x2 and methods of using
12/13/2011CA2267851C Bordetella strain expressing the fha hybrid, liposomes and vaccines
12/13/2011CA2229203C Antigenic preparations from keratinophilic fungi
12/08/2011WO2011153532A1 Peptide particle formulation
12/08/2011WO2011153351A2 Novel modified live-attenuated vaccines (mlv) and subunit vaccines created by dna shuffling against porcine reproductive and respiratory syndrome virus (prrsv)
12/08/2011WO2011153277A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-trna synthetases
12/08/2011WO2011153243A2 Anti-angiogenesis therapy for treating gastric cancer
12/08/2011WO2011153209A2 Cd36 inhibition to control obesity and insulin sensitivity
12/08/2011WO2011152716A2 Dispensing unit and method for dispensing a liquid under pressure
12/08/2011WO2011152525A1 Antibody and use thereof
12/08/2011WO2011152503A1 Treatment drug for autoimmune diseases and allergic diseases
12/08/2011WO2011152071A1 Novel hyaluronic acid decomposition-promoting factor and inhibitor thereof
12/08/2011WO2011151760A2 Vaccine formulations
12/08/2011WO2011151471A1 Novel immunoadjuvant compounds and uses thereof
12/08/2011WO2011151449A1 Pharmaceutical product comprising mite allergen extract(s) and a method for the manufacture thereof
12/08/2011WO2011151432A1 Humanised antigen binding proteins to myostatin6
12/08/2011WO2011151431A1 Oral vaccine comprising an antigen and a toll-like receptor agonist
12/08/2011WO2011151412A1 Novel anti-cmet antibody
12/08/2011WO2011151403A1 Improved cancer therapy based on tumor associated antigens derived from cyclin d1